These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33534341)

  • 1. Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice.
    Hu G; Zhu Q; Wang W; Xie D; Chen C; Li PL; Ritter JK; Li N
    J Hypertens; 2021 Aug; 39(8):1559-1566. PubMed ID: 33534341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Medullary Overexpression of Sphingosine-1-Phosphate Receptor 1 Transgene Attenuates Deoxycorticosterone Acetate (DOCA)-Salt Hypertension.
    Hu G; Xie D; Chen C; Wang W; Li PL; Ritter JK; Li N
    Am J Hypertens; 2023 Aug; 36(9):509-516. PubMed ID: 37171128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
    Lyu B; Wang W; Ji XY; Ritter JK; Li N
    BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice.
    Gross V; Lippoldt A; Bohlender J; Bader M; Hansson A; Luft FC
    J Am Soc Nephrol; 1998 Mar; 9(3):346-54. PubMed ID: 9513896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collecting Duct Renin Does Not Mediate DOCA-Salt Hypertension or Renal Injury.
    Song K; Stuart D; Abraham N; Wang F; Wang S; Yang T; Sigmund CD; Kohan DE; Ramkumar N
    PLoS One; 2016; 11(7):e0159872. PubMed ID: 27467376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
    Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
    Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.
    Yao B; Harris RC; Zhang MZ
    Hypertension; 2009 Nov; 54(5):1077-83. PubMed ID: 19770404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
    Wang Y; Wang DH
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
    Katholi RE; Naftilan AJ; Bishop SP; Oparil S
    Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP.
    Jia Z; Aoyagi T; Yang T
    Hypertension; 2010 Feb; 55(2):539-46. PubMed ID: 20065149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARRB2 (β-Arrestin-2) Deficiency Alters Fluid Homeostasis and Blood Pressure Regulation.
    Mathieu NM; Nakagawa P; Grobe CC; Reho JJ; Brozoski DT; Lu KT; Wackman KK; Ritter ML; Segar JL; Grobe JL; Sigmund CD
    Hypertension; 2022 Nov; 79(11):2480-2492. PubMed ID: 36215165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.
    Jennings BL; Estes AM; Anderson LJ; Fang XR; Yaghini FA; Fan Z; Gonzalez FJ; Campbell WB; Malik KU
    Hypertension; 2012 Dec; 60(6):1510-6. PubMed ID: 23108654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
    Manhiani M; Quigley JE; Knight SF; Tasoobshirazi S; Moore T; Brands MW; Hammock BD; Imig JD
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F740-8. PubMed ID: 19553349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1 deletion affects renal sympathetic nerve activity, left ventricular dysfunction, and renal function in DOCA-salt hypertensive mice.
    Xiao B; Liu F; Lu JC; Chen F; Pei WN; Yang XC
    Physiol Res; 2019 Apr; 68(2):209-217. PubMed ID: 30628826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice.
    Ighodaro I; Eric OK; Adebayo O
    Niger J Physiol Sci; 2013 Dec; 28(2):127-33. PubMed ID: 24937386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension.
    Wu Y; An C; Jin X; Hu Z; Wang Y
    Sci Rep; 2020 Jan; 10(1):133. PubMed ID: 31924817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
    Elmarakby AA; Quigley JE; Imig JD; Pollock JS; Pollock DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R76-83. PubMed ID: 17989143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collecting duct function in deoxycorticosterone acetate-escaped, normal, and salt-deprived rats. Response to hypervolemia.
    Sonnenberg H
    Circ Res; 1976 Aug; 39(2):282-8. PubMed ID: 939014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Sclerosis Drug Fingolimod Induces Thrombotic Microangiopathy in Deoxycorticosterone Acetate/Salt Hypertension.
    Iwazu Y; Muto S; Ioka T; Watanabe Y; Iwazu K; Kusano E; Nagata D
    Hypertension; 2018 Sep; 72(3):776-784. PubMed ID: 30354753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.